neoplasm
• mice exhibit a spectrum of urothelial neoplasia ranging from dysplasia to muscle-invasive urothelial carcinoma that resembles human urothelial carcinomas
• 14% of mice develop only low-grade noninvasive tumors
• 29% of mice develop either invasive carcinoma or carcinoma-in-situ
• all invasive tumors show muscle invasion and muscle-invasive tumors consist of malignant cells infiltrating into the muscularis
• papillary carcinomas are multifocal with fibrovascular stalks projecting into the bladder lumen
• PTEN protein expression is lost in both noninvasive and muscle-invasive bladder cancers
|
renal/urinary system
• mice exhibit a spectrum of urothelial neoplasia ranging from dysplasia to muscle-invasive urothelial carcinoma that resembles human urothelial carcinomas
• 14% of mice develop only low-grade noninvasive tumors
• 29% of mice develop either invasive carcinoma or carcinoma-in-situ
• all invasive tumors show muscle invasion and muscle-invasive tumors consist of malignant cells infiltrating into the muscularis
• papillary carcinomas are multifocal with fibrovascular stalks projecting into the bladder lumen
• PTEN protein expression is lost in both noninvasive and muscle-invasive bladder cancers
|
• mice develop bladder outlet obstruction secondary to tumor formation starting at 8 months of age
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
urinary bladder cancer | DOID:11054 |
OMIM:109800 |
J:226764 |